Unknown

Dataset Information

0

Identification of Bioactive Compounds from Marine Natural Products and Exploration of Structure-Activity Relationships (SAR).


ABSTRACT: Marine natural products (MNPs) have been an important and rich source for antimicrobial drug discovery and an effective alternative to control drug resistant infections. Herein, we report bioassay guided fractionation of marine extracts from sponges Lendenfeldia, Ircinia and Dysidea that led us to identify novel compounds with antimicrobial properties. Tertiary amines or quaternary amine salts: aniline 1, benzylamine 2, tertiary amine 3 and 4, and quaternary amine salt 5, along with three known compounds (6-8) were isolated from a crude extract and MeOH eluent marine extracts. The antibiotic activities of the compounds, and their isolation as natural products have not been reported before. Using tandem mass spectrometry (MS) analysis, potential structures of the bioactive fractions were assigned, leading to the hit validation of potential compounds through synthesis, and commercially available compounds. This method is a novel strategy to overcome insufficient quantities of pure material (NPs) for drug discovery and development which is a big challenge for pharmaceutical companies. The antibacterial screening of the marine extracts has shown several of the compounds exhibited potent in-vitro antibacterial activity, especially against methicillin-resistant Staphylococcus aureus (MRSA) with minimum inhibitory concentration (MIC) values between 15.6 to 62.5 microg mL-1. Herein, we also report structure activity relationships of a diverse range of commercial structurally similar compounds. The structure-activity relationships (SAR) results demonstrate that modification of the amines through linear chain length, and inclusion of aromatic rings, modifies the observed antimicrobial activity. Several commercially available compounds, which are structurally related to the discovered molecules, showed broad-spectrum antimicrobial activity against different test pathogens with a MIC range of 50 to 0.01 µM. The results of cross-referencing antimicrobial activity and cytotoxicity establish that these compounds are promising potential molecules, with a favourable therapeutic index for antimicrobial drug development. Additionally, the SAR studies show that simplified analogues of the isolated compounds have increased bioactivity.

SUBMITTER: Dinarvand M 

PROVIDER: S-EPMC8004798 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4557015 | biostudies-literature
| S-EPMC4003108 | biostudies-other
| S-EPMC9031984 | biostudies-literature
| S-EPMC9777303 | biostudies-literature
| S-EPMC7042511 | biostudies-literature
| S-EPMC5135737 | biostudies-literature
2021-08-17 | GSE147996 | GEO
| S-EPMC5267508 | biostudies-literature
| S-EPMC10201022 | biostudies-literature
| S-EPMC6315899 | biostudies-literature